HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peroxidase antiperoxidase versus specific red cell adherence in detection of O (H) antigen in bladder cancer: a blind study.

Abstract
We have previously demonstrated that the presence or absence of ABO(H) cell surface antigens correlated with stage, grade, and prognosis of patients with bladder cancer. However, because of the weak antigenecity of 0(H), certain investigators have reported a high rate of false-negative results utilizing specific red cell adherence (SRCA) test of Davidsohn. Since approximately 45% of the population is blood group O(H), this high rate of false-negative result renders the test unreliable in an ordinary laboratory. The present study is comparing the results of SRCA to that of peroxidase antiperoxidase (PAP) technique in a double-blind fashion in 29 patients with bladder cancer having O(H) blood group. In terms of grade, stage, frequency of recurrent tumor, and quality of slides, the results of PAP is superior over SRCA. Furthermore, the convenience, permanence, and ready availability of PAP will enhance the utility of this test in a conventional histopathologic laboratory with a high rate of accuracy and reproducibility.
AuthorsN Javadpour, J Vafrier, G F Worsham, K O'Connel
JournalJournal of surgical oncology (J Surg Oncol) Vol. 27 Issue 2 Pg. 112-5 (Oct 1984) ISSN: 0022-4790 [Print] United States
PMID6384666 (Publication Type: Clinical Trial, Comparative Study, Journal Article)
Chemical References
  • ABO Blood-Group System
Topics
  • ABO Blood-Group System
  • Clinical Trials as Topic
  • Double-Blind Method
  • Erythrocytes (immunology)
  • Humans
  • Immunoenzyme Techniques
  • Neoplasm Staging
  • Prognosis
  • Rosette Formation
  • Urinary Bladder Neoplasms (blood, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: